Clinical Trials
INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
Inovio Pharmaceuticals, Inc.
PR-10-24-NI-53Oct 21, 2024
COVID-19
INOVIO Announces Positive Interim Phase 1 Data For INO-4800 Vaccine for COVID-19
Nice Insight
PR-M06-20-NI-039Jun 30, 2020
COVID-19
INOVIO Receives $71 Million Contract from U.S. Department of Defense to Scale Up Manufacture of COVID-19 DNA Vaccine Delivery Device
Inovio Pharmaceuticals, Inc.
PR-M06-20-NI-030Jun 23, 2020
Vaccine
Inovio First to Advance Lassa Fever Candidate Vaccine Into a Clinical Trial
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-074May 28, 2019
Phase III
Inovio Receives European Medicines Agency Certification For Quality and Non-Clinical Data for Its Phase 3 Product, VGX-3100
Inovio Pharmaceuticals, Inc.
PR-M05-19-NI-022May 08, 2019
Immunotherapy
Deal with Inovio Launches ApolloBio’s Commercialization Plans in China
Guy Tiene
Nice Insight
PAO-M01-18-NI-009Jan 05, 2018
Clinical Trials
HIV Vaccine Demonstrates “Remarkable” Rates
Emilie Branch
Pharma's Almanac
PAO-M05-17-NI-039May 31, 2017